ISRG logo

ISRG
Intuitive Surgical Inc

19,619
Mkt Cap
$165.88B
Volume
25,339.00
52W High
$616.00
52W Low
$425.00
PE Ratio
64.57
ISRG Fundamentals
Price
$539.00
Prev Close
$458.47
Open
$459.47
50D MA
$454.49
Beta
1.22
Avg. Volume
2.65M
EPS (Annual)
$6.42
P/B
9.29
Rev/Employee
$534,090.04
Loading...
Loading...
News
all
press releases
Intuitive Surgical Stock Soars 17% After-Hours On Strong Q3 Print, Robotics Adoption Surge — Retail Sees ‘Rush Of Buyers’
Stocktwits·6h ago
News Placeholder
More News
News Placeholder
Intuitive Surgical, Inc. (ISRG) Q3 Earnings and Revenues Top Estimates
Intuitive Surgical (ISRG) delivered earnings and revenue surprises of +20.60% and +3.92%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·11h ago
News Placeholder
Will Intuitive Surgical (ISRG) Beat Estimates Again in Its Next Earnings Report?
Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·17h ago
News Placeholder
Earnings Preview: OrthoPediatrics (KIDS) Q3 Earnings Expected to Decline
OrthoPediatrics (KIDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·20h ago
News Placeholder
Will ISRG's dV5 Lend Momentum to Top Line During Q3 Earnings?
Intuitive Surgical's new da Vinci 5 is driving strong hospital upgrades and premium pricing, setting up ISRG for potential top-line momentum in Q3.
Zacks·21h ago
News Placeholder
Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval
STXS expands its digital surgery vision with the EU launch of its Synchrony System and an FDA submission for market entry.
Zacks·2d ago
News Placeholder
Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now?
Intuitive Surgical enters Q3 earnings season on strong momentum, backed by robust procedure growth and da Vinci 5 adoption. However, tariff risks and global CapEx constraints remain challenges.
Zacks·5d ago
News Placeholder
Markets Mostly Up, Russell 2000 Sets New Closing High
The biggest movers on the day were the Nasdaq, +148 points or +0.66%, and the small-cap Russell 2000 +24 points, +0.97%.
Zacks·6d ago
News Placeholder
Can Ion Emerge as ISRG's Vehicle to Tap Ambulatory Care Growth?
Intuitive Surgical's Ion platform gains traction in ambulatory centers, driving 52% growth as outpatient lung diagnostics accelerate.
Zacks·7d ago
News Placeholder
Can ISRG Continue Its Strong Growth Amid Tariff & Rare Earth Woes?
ISRG's growth momentum faces pressure as tariffs and China's rare earth export curbs threaten margins and supply stability.
Zacks·8d ago

Latest ISRG News

View

Advertisement|Remove ads.

Advertisement|Remove ads.